The company has a collaboration with Flavocure Biotech, Inc., for the identification and development of certain natural molecules. The company is actively pursuing some of the most virulent diseases, with a focus on SARS-Cov-2 (COVID-19).
In light of compelling scientific data, a panel of researchers have concluded that the drug Caflanone should be considered for clinical trials. This effort has been named ENDEAVOR-1 – Beating COVID-19.